Investor Stock List
Ranked #5,618 of 8,699 institutional investors

5AM Venture Management, LLC

San Francisco, CA

$241M
US stock portfolio at live prices · today −$1.1M (−0.45%)
Live prices, last trade 10:20 AM ET
Value at quarter end (Q3 2026)
$297M
Change from Q2 2026
+$9.1M (+3.17%)
Positions
14 · 1 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$25.1M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
LTGO 39.7%CAMP 8.66%TYRA 8.66%TRDA 7.09%TECX 5.32%
StockSharesValue, live% of portfoliovs Q2 2026
LTGO Latigo Biotherapeutics, Inc.7,325,962$95.5M39.7%New
CAMP Camp4 Therapeutics Corp5,277,216$20.8M8.66%Reduced −10%
TYRA Tyra Biosciences, Inc.1,029,298$20.8M8.66%Unchanged
TRDA Entrada Therapeutics, Inc.3,784,650$17.0M7.09%Reduced −7%
TECX Tectonic Therapeutic, Inc.606,660$12.8M5.32%Unchanged
CLDX Celldex Therapeutics, Inc.422,270$11.6M4.84%Reduced −15%
SLN Silence Therapeutics plc476,200$9.4M3.92%Unchanged
ARTV Artiva Biotherapeutics, Inc.2,353,304$9.2M3.81%Unchanged
ZNTL Zentalis Pharmaceuticals, Inc.3,947,913$5.8M2.41%Unchanged
MPLT MapLight Therapeutics, Inc.741,893$4.7M1.95%Reduced −22%
ALXO ALX Oncology Holdings Inc.3,057,325$3.4M1.40%Unchanged
TARA Protara Therapeutics, Inc.1,369,782$3.3M1.37%Unchanged
SKYE Skye Bioscience, Inc.981,269$765K0.32%Reduced −19%
EYPT EyePoint, Inc.1,050,000$272K0.11%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
SRZN Surrozen, Inc.271,250$8.1M